Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Metastases × Positron Emission Tomography Computed Tomography × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasms 2 Neoplasm Metastasis 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Neoplastic Cells, Circulating 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Breast Cancer Metastases 1

Interventions

zirconium-89-trastuzumab 1 Positron Emission Tomography Computed Tomography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02286843 2021-06-18

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

Memorial Sloan Kettering Cancer Center

Phase NA Completed

49 enrolled 8 charts

Breast Cancer Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡